Skip to content

Clinical trials

Overweight trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Germany Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20064
20073
20083
20093
20102
20116
20124
20131
20142
20151
20161
20176
20187
201911
20204
20216
20224
20239
202411
202525
202629

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Recruiting33
Active, not recruiting20
Unknown status7
Terminated4
Not yet recruiting3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S22
Eli Lilly and Company19
InQpharm Group10
West German Center of Diabetes and Health7
German Institute of Human Nutrition6
Zealand Pharma6
Amgen5
AstraZeneca5
University of Erlangen-Nürnberg Medical School5
Certmedica International GmbH3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight146
Obesity122
Diabetes Mellitus, Type 227
Weight Loss18
Body Weight11
Metabolic Syndrome11
Diabetes Mellitus7
Metabolic Diseases6
Nutrition Disorders6
Inflammation5

Trials

Showing 26 to 50 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.